Tekla Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$8.32M	Sell	131,435 -40,936	-24%	-$2.59M	0.33%	64
2023 Q1	$9.33M	Hold	172,371	–	–	0.36%	59
2022 Q4	$9.12M	Hold	172,371	–	–	0.34%	59
2022 Q3	$8.02M	Sell	172,371 -71,066	-29%	-$3.31M	0.33%	60
2022 Q2	$13.9M	Sell	243,437 -47,499	-16%	-$2.71M	0.55%	53
2022 Q1	$17.8M	Buy	290,936 +54,489	+23%	+$3.33M	0.63%	42
2021 Q4	$12.4M	Sell	236,447 -87,954	-27%	-$4.6M	0.4%	58
2021 Q3	$12.1M	Buy	324,401 +121,645	+60%	+$4.54M	0.39%	62
2021 Q2	$8.28M	Sell	202,756 -29,720	-13%	-$1.21M	0.27%	95
2021 Q1	$7.89M	Sell	232,476 -133,700	-37%	-$4.54M	0.27%	94
2020 Q4	$11.6M	Buy	366,176 +271,938	+289%	+$8.65M	0.41%	72
2020 Q3	$2.42M	Hold	94,238	–	–	0.09%	142
2020 Q2	$2.42M	Hold	94,238	–	–	0.09%	152
2020 Q1	$1.45M	Hold	94,238	–	–	0.07%	153
2019 Q4	$3.23M	Buy	94,238 +66,690	+242%	+$2.29M	0.12%	134
2019 Q3	$206K	Sell	27,548 -27,548	-50%	-$206K	0.01%	181
2019 Q2	$715K	Sell	55,096 -55,097	-50%	-$715K	0.03%	174
2019 Q1	$1.34M	Hold	110,193	–	–	0.05%	146
2018 Q4	$1.26M	Buy	110,193 +75,343	+216%	+$858K	0.05%	153
2018 Q3	$756K	Buy	+34,850	New	+$756K	0.03%	186
2016 Q3	–	Sell	-187,800	Closed	-$7.29M	–	145
2016 Q2	$7.29M	Hold	187,800	–	–	0.3%	72
2016 Q1	$5.22M	Hold	187,800	–	–	0.22%	83
2015 Q4	$10.1M	Buy	187,800 +37,800	+25%	+$2.03M	0.37%	58
2015 Q3	$6.01M	Sell	150,000 -77,164	-34%	-$3.09M	0.22%	83
2015 Q2	$7.26M	Buy	227,164 +77,164	+51%	+$2.47M	0.26%	69
2015 Q1	$3.58M	Buy	+150,000	New	+$3.58M	0.14%	82